Mark A. Glickman - Jun 7, 2024 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role
Director
Signature
/s/ Phillip D. Torrence, by Power of Attorney
Stock symbol
NRBO
Transactions as of
Jun 7, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 07:25 PM
Previous filing
Jul 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRBO Common Stock Award $0 +5.05K +107.72% $0.00 9.74K Jun 7, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's 2022 Equity Incentive Plan, which vests on the earlier of June 7, 2025 or the day immediately prior to the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date.
F2 The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.